300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Isle of Man
Kyrgyzstan
Pakistan
Romania
Colombia
Oman
Cameroon
Australia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Cayman Islands
Kenya
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Botswana
Malawi
Moldova
Seychelles
Japan
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Indonesia
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device Startup Investors in France (July 2026)

The most active venture capital funds and angel investors investing in France Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
28 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $726k–$34M
GO CAPITAL
VC Fund
13 France, Canada, Israel Seed, Series A Biotechnology, Software, Health Care $549k–$13M
Elaia
VC Fund
12 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Karista
VC Fund
11 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $713k–$33M
Sofinnova Partners
VC Fund
10 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
Sofimac Investment Managers
VC Fund
10 France, Italy, Austria Seed, Series A Biotechnology, Health Care, Manufacturing $274k–$15M
Seventure Partners
VC Fund
10 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.1M–$65M
Angels Santé
VC Fund
9 France, India, United States Seed, Angel Health Care, Biotechnology, Medical Device $658k–$4.6M
Kurma Partners
VC Fund
9 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.3M–$95M
IRDI
VC Fund
9 France Series A, Seed Health Care, Software, Biotechnology $757k–$22M
M Capital Partners
VC Fund
8 France, United States, Canada Seed, Series A Health Care, Software, Food and Beverage $1.1M–$7.7M
Newfund
VC Fund
8 France, United States, Canada Seed, Series A Software, Information Technology, SaaS $1.1M–$15M
Crédit Agricole
VC Fund
7 France, United States, Italy Debt Financing, Seed Energy, Health Care, Software $768k–$1.3B
UI Investissement
VC Fund
7 France, Spain, Canada Private Equity, Seed, Series A Manufacturing, Software, Health Care $1.5M–$49M
Omnes Capital
VC Fund
6 France, Germany, United States Series A, Series B Software, Biotechnology, Health Care $3.5M–$53M
BNP Paribas Développement
VC Fund
6 France, Germany, The Netherlands Series A, Seed Software, Health Care, Information Technology $2M–$25M
Finovam Gestion
VC Fund
6 France, United States Seed, Series A Software, Information Technology, Medical $505k–$12M
Idinvest Partners
VC Fund
6 France, United States, Spain Series B, Series A Biotechnology, Software, Health Care $3.3M–$66M
Nord France Amorcage
VC Fund
5 France, United States Seed, Series A Software, Information Technology, Health Care $329k–$25M
WiSEED
VC Fund
5 France, Norway Seed, Equity Crowdfunding Software, Biotechnology, Manufacturing $384k–$3.3M
Supernova Invest
VC Fund
5 France, Switzerland, United States Series A, Series B Manufacturing, Health Care, Medical Device $6.6M–$60M
iBionext
VC Fund
5 France Series A, Series B Medical Device, Artificial Intelligence, Drones $7.7M–$39M
IRDI SORIDEC Gestion
VC Fund
4 France, Brazil, Singapore Seed, Series A Software, Biotechnology, Medical $1.6M–$13M
Galia Gestion
VC Fund
4 France, United States Series A, Seed Software, Manufacturing, Biotechnology $531k–$6.9M
Inserm Transfert Initiative
VC Fund
4 France, Switzerland, United States Series A, Series B, Seed Biotechnology, Medical, Health Care $1.1M–$60M
Kima Ventures
VC Fund
4 France, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $550k–$16M
XAnge
VC Fund
4 France, Germany, Belgium Series A, Seed, Series B Software, SaaS, E-Commerce $1.1M–$68M
AQUITI Gestion
VC Fund
3 France, United States Series A, Seed Software, Biotechnology, Manufacturing $170k–$18M
Sodero Gestion
VC Fund
3 France Seed, Series A Software, Information Technology, Telecommunications $219k–$6.5M
Pontifax
VC Fund
3 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$128M
Auriga Partners
VC Fund
3 France, United States, Switzerland Series B, Series A Biotechnology, Health Care, Medical $2.2M–$33M
IT-Translation
VC Fund
3 France Seed, Series A Software, SaaS, Medical Device $329k–$12M
Polytechnique Ventures
VC Fund
3 France, United Kingdom, United States Seed, Series A, Pre-Seed Biotechnology, Robotics, Information Technology $1.3M–$17M
Better Angle
VC Fund
3 France, United States, United Kingdom Seed, Pre-Seed Artificial Intelligence, Software, Information Technology $500k–$8.7M
NACO
VC Fund
3 France Seed, Series A Health Care, Medical Device, Information Technology $658k–$24M
Capital Grand Est
VC Fund
3 France Seed, Series A Health Care, Biotechnology, Medical Device $1.1M–$19M
ACG Management
VC Fund
3 France, Madagascar Seed, Series A Software, Health Care, Biotechnology $878k–$7.2M
LBO France
VC Fund
3 France, United Kingdom, Spain Series A, Venture - Series Unknown, Series B Health Care, Software, Medical $2.4M–$191M
Mutuelles Impact
VC Fund
3 France, Germany, Switzerland Seed, Venture - Series Unknown Health Care, Medical Device, Software $2.3M–$25M
Mérieux Equity Partners
VC Fund
3 France, United States, Belgium Series A, Private Equity Health Care, Biotechnology, Medical Device $5.7M–$150M
IXcore
VC Fund
3 France, Israel Seed, Pre-Seed, Series A Manufacturing, Medical Device, Information Technology $1.1M–$17M
Sham Innovation Santé
VC Fund
3 France Series B, Series A Biotechnology, Medical Device, Medical $5.7M–$80M
Région Sud Investissement
VC Fund
3 France, Spain Seed, Series A Software, Information Technology, Manufacturing $1.1M–$22M
Pays de la Loire Participations
VC Fund
3 France Seed, Private Equity Manufacturing, Software, Information Technology $549k–$3.3M
MD Start
VC Fund
3 France Seed, Series B Medical Device, Health Care, Medical
Crédit Mutuel Innovation
VC Fund
3 France, United States, Canada Series A, Series B Software, Health Care, Biotechnology $3.3M–$43M
Cap Innov'Est
VC Fund
3 France, United States Seed, Series A Biotechnology, Medical, Health Care $713k–$7.7M
European Investment Bank
VC Fund
3 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$658M
ODYSSEE VENTURE
VC Fund
3 France, United States Series A, Private Equity Software, Information Technology, Analytics $1.6M–$11M
MACSF
VC Fund
3 France, Spain, Ecuador Series A, Seed Health Care, Medical, Medical Device $1.1M–$44M
Access all 503 investors in France Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 28 investments in France Medical Device startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1274
  • Round size: Seed $726k–$6.5M; Series A $2.7M–$34M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Hublo — Hublo builds a simple and user-friendly digital platform to help hospitals, clinics and retirement homes find staff easily and efficiently, so that they can refocus on their core mission: saving lives.
  • AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 13 investments in France Medical Device startups

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 137
  • Round size: Seed $549k–$6.6M; Series A $2.1M–$13M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
  • Axomove — Axomove is an e-health app that specializes in video physical exercises.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 12 investments in France Medical Device startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 218
  • Round size: Seed $1.1M–$9.9M; Series A $2.2M–$26M; Series B $4.2M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
  • Nano Corp — Deep network analysis for everyone
  • Vibe — Advertise your brand on CTV & OTT content with Vibe's self-serve ad platform to target hundreds of channels & networks and reach millions of households.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 11 investments in France Medical Device startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 150
  • Round size: Seed $713k–$6.5M; Series A $1.2M–$23M; Series B $2.5M–$33M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • Acticor Biotech — Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 milliondies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains.Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 10 investments in France Medical Device startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 319
  • Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
  • GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 10 investments in France Medical Device startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 73
  • Round size: Seed $274k–$2.2M; Series A $1.6M–$15M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 10 investments in France Medical Device startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 239
  • Round size: Series A $3.1M–$27M; Series B $3.4M–$65M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • ErVimmune — Our team is focused on bringing breakthrough immunotherapies in unmet medical needs for cancer patients. Check our work!
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • BAOUW / Outdoor Organic Nutrition — A raw, healthy, and natural diet made up of energy gels, energy bars, and energy fruit purees.
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 9 investments in France Medical Device startups

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$4.6M; Angel $658k–$1.3M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • StemInov — StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC).
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in France Medical Device startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 138
  • Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

IRDI
VC Fund · Toulouse, Midi-Pyrenees, France · 9 investments in France Medical Device startups

IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: France

Investor stats

  • Total investments: 45
  • Round size: Seed $757k–$9.2M; Series A $1.6M–$22M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • FineHeart — Our mission is to address the unmet need of patients with sever heart failure
  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 8 investments in France Medical Device startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 110
  • Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Haiku — Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.
The company's objective is to free lawyers from tedious research and writing tasks to assist them in all of their work and thus increase their productivity while preserving their expertise.
  • MilkStraw AI — Saving companies up to 75% on AWS
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
Show all investments...

Newfund
VC Fund · Paris, Ile-de-France, France · 8 investments in France Medical Device startups

Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 183
  • Round size: Seed $1.1M–$6M; Series A $2.2M–$15M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Moodwork — Moodwork is the digital solution for Quality of Life at Work. Numerous scientific research around the quality of life at work has led to a better knowledge of the professional world.
  • AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
  • Brightflow AI — Self driving finance: Simple and easy analysis on cash flow
Show all investments...

Crédit Agricole
VC Fund · Paris, Ile-de-France, France · 7 investments in France Medical Device startups

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Show more...

Investment focus

  • Industry: Energy, Health Care, Software
  • Stage:Debt Financing, Seed
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 173
  • Round size: Seed $768k–$6M; Debt Financing $2.1M–$1.3B
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Crelan — Crelan is a co-operative bank that offers a wide range of banking and insurance products to individuals and entrepreneurs.
  • BCC — BCC is a provider of banking and financial services.
  • DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
Show all investments...

UI Investissement
VC Fund · Paris, Ile-de-France, France · 7 investments in France Medical Device startups

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Health Care
  • Stage:Private Equity, Seed, Series A
  • Geography: France, Spain, Canada

Investor stats

  • Total investments: 105
  • Round size: Seed $1.5M–$6.6M; Series A $3.3M–$33M; Private Equity $3.1M–$49M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $37M in 2021

Portfolio highlights

  • Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
  • Bobine Chemistry
  • B Capital Partners — B Capital Partners is a financial services firm offering investment advisory solutions with a focus on infrastructure and clean energy.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in France Medical Device startups

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 181
  • Round size: Series A $3.5M–$44M; Series B $4.4M–$53M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $403M in 2020

Portfolio highlights

  • VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Show all investments...

BNP Paribas Développement
VC Fund · Paris, Ile-de-France, France · 6 investments in France Medical Device startups

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 145
  • Round size: Seed $2M–$10M; Series A $3.8M–$25M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Lucine — Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement andanalysis of the pain by facial, vocal and postural recognition.
  • Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

Finovam Gestion
VC Fund · Villeneuve, Provence-Alpes-Cote d'Azur, France · 6 investments in France Medical Device startups

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Show more...

Investment focus

  • Industry: Software, Information Technology, Medical
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $505k–$3.4M; Series A $549k–$12M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Pikkopay — Pikkopay provides a mobile payment solution that transforms customer smartphones into cash registers. Customers can scan items, pay, and go, eliminating the need for traditional checkout lines. The service aims to streamline the shopping experience and increase user retention rates. Pikkopay is designed to save time for both customers andretailers, offering a hassle-free shopping experience.
  • StemInov — StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC).
  • Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 6 investments in France Medical Device startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 252
  • Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • LumApps — LumApps is the only intranet packaged solution that enables employees to feel connected to their organization and engaged in their work from anywhere by delivering a modern, smart digital headquarters that empowers your employees to design a work experience that works for them.
  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
Show all investments...

Nord France Amorcage
VC Fund · Lille, Nord-Pas-de-Calais, France · 5 investments in France Medical Device startups

Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 40
  • Round size: Seed $329k–$2.8M; Series A $1.1M–$25M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
  • Hemerion — Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
  • Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 5 investments in France Medical Device startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Equity Crowdfunding
  • Geography: France, Norway

Investor stats

  • Total investments: 31
  • Round size: Seed $384k–$3.3M; Equity Crowdfunding $466k–$2.7M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Supernova Invest
VC Fund · Paris, Ile-de-France, France · 5 investments in France Medical Device startups

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical Device
  • Stage:Series A, Series B
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 100
  • Round size: Series A $6.6M–$30M; Series B $7.7M–$60M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Heliup — Heliup is a company that creates and manufactures solar systems for huge building roofs for commercial and industrial buildings.
  • Quobly — Quobly create and market a universal large-scale quantum computer, using tried-and-true semiconductor industry procedures.
  • CrowdSec — CrowdSec is an open-source and collaborative security stack leveraging the crowd power. Analyze behaviors, respond to attacks & share signals across the community. Join the community and le's make the Internet safer, together.
Show all investments...

iBionext
VC Fund · Paris, Ile-de-France, France · 5 investments in France Medical Device startups

iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.

Show more...

Investment focus

  • Industry: Medical Device, Artificial Intelligence, Drones
  • Stage:Series A, Series B
  • Geography: France

Investor stats

  • Total investments: 14
  • Round size: Series A $7.7M–$15M; Series B $15M–$39M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2018

Portfolio highlights

  • BrainEver — BrainEver is developing a portfolio of drug candidates focused on major neurodegenerative diseases with significant unmet medical needs: ALS, Parkinson, and
  • Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
  • Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France · 4 investments in France Medical Device startups, 7 in the past 12 months

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: France, Brazil, Singapore

Investor stats

  • Total investments: 53
  • Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
  • Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
  • DiappyMed — DiappyMed specializes in developing platforms to calculate insulin dosages.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 4 investments in France Medical Device startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2013

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France · 4 investments in France Medical Device startups

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 22
  • Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.2M–$60M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
Show all investments...

Kima Ventures
VC Fund · Paris, Ile-de-France, France · 4 investments in France Medical Device startups

Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 574
  • Round size: Seed $550k–$5.5M; Pre-Seed $587k–$4.2M; Series A $1.2M–$16M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Hoora
  • Macrodata Labs — Macrodata Labs is a technology company that provides data infrastructure for the artificial intelligence and robotics industries.
  • Explora Project — Explora Project is specializing in adventure travel and expeditions to the 4 corners of the planet and all environments.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 4 investments in France Medical Device startups

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: France, Germany, Belgium

Investor stats

  • Total investments: 218
  • Round size: Seed $1.1M–$7.6M; Series A $3M–$20M; Series B $6.6M–$68M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $234M in 2021

Portfolio highlights

  • Dogami — Dogami is a mass-market NFT play-to-earn game that is centered around 3D NFT dog avatars.
  • Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
  • Goodays (ex Critizr) — Critizr Connection is a Customer Interaction Management Platform that helps brands become customer-obsessed and deliver memorable customer experiences.
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 3 investments in France Medical Device startups

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 58
  • Round size: Seed $170k–$4.1M; Series A $849k–$18M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $6.4M in 2010

Portfolio highlights

  • Synboli
  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Show all investments...

Sodero Gestion
VC Fund · Nantes, Pays de la Loire, France · 3 investments in France Medical Device startups

Sodero Management has 70 million of capital it intends to finance for SMEs. These funds come from the Caisse d'Epargne and Caisse des Depots et Consignations, firstly, of Brittany and Pays de la Loire, on the other. But also individuals from which € 26m was raised in 5 years through FIP (Local Investment Fund sold each year by the SavingsBank from November). And local savings will directly feed the local economy while enjoying immediate tax benefits.

Show more...

Investment focus

  • Industry: Software, Information Technology, Telecommunications
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 21
  • Round size: Seed $219k–$2.2M; Series A $713k–$6.5M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Grimp — Saas solution to manage your job search in one place.
  • D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
  • BioMAdvanced Diagnostics — Online138 menghadirkan festival terbesar yang didalamnya terdapat hiburan online tanpa batas dengan bekerja sama bersama GGSoft yang paten dan gampang menang hari ini.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in France Medical Device startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 113
  • Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Graviton Bioscience — Curing Disease through Restored Homeostasis
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Auriga Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 128
  • Round size: Series A $2.2M–$14M; Series B $3.8M–$33M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Availpro — D-EDGE empowers 17,000+ hotels to boost revenue with CRS, Booking Engine, Channel Manager, hospitality-focused websites & digital marketing solutions.
  • Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
  • Bonitasoft — Bonita helps businesses automate workflows, boost efficiency, and turn complexity into a competitive edge. Unlock the power of process automation today!
Show all investments...

IT-Translation
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

IT-Translation: investor and co-founder of digital technology start-ups developed from research

Show more...

Investment focus

  • Industry: Software, SaaS, Medical Device
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 13
  • Round size: Seed $329k–$768k; Series A $549k–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AntsRoute — AntsRoute is a cloud-based route planning & optimization software developed by the French startup Antsway in 2015. The solutions help professionals to create optimal delivery, pick-up and multi-stop routes. The routing software makes it easier to smartly schedule appointments, optimize daily routes, automate dispatch to drivers, track theirprogress in real-time and keep customers updated with SMS alerts. The best software to increase stops per route, cut down transport costs and planning time.
  • Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Show all investments...

Polytechnique Ventures
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

Polytechnique Ventures support entrepreneurs from the School's ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 24
  • Round size: Seed $2M–$11M; Pre-Seed $1.3M–$1.8M; Series A $6.5M–$17M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
  • Jimmy — Jimmy is a supplier of carbon-free industrial heat to industrialists. The company designs and markets turnkey thermal generators, connected to the heating circuits of factories. These generators rely on a nuclear micro-reactor to create heat.
  • One Biosciences — One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases. Magali Richard, David Schilansky, and Céline Vallot co-founded the company in Paris, Ile-de-France, France.
Show all investments...

Better Angle
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

We back the companies of tomorrow before it's obvious. Strategic venture capital firm committed to building lasting partnerships with exceptional founders.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 71
  • Round size: Seed $1.6M–$6.4M; Pre-Seed $500k–$8.7M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Rentr — Rentr gives next-gen property management solutions.
  • Beavr — Automate your ESG compliance and streamline your CSR operations. Meet your stakeholders' expectation in days not months.
  • Nepsis — Nepsis enables businesses to adopt solar and clean energy solutions with zero upfront cost through smart financing and leasing solutions.
Show all investments...

NACO
VC Fund · Bordeaux, Aquitaine, France · 3 investments in France Medical Device startups

NACO is a co-investment fund for start-ups and small and medium-sized businesses (SMEs). NACO is a regional co-investment fund backed by Région Nouvelle-Aquitaine and managed by M/Capital Partners.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Information Technology
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 19
  • Round size: Seed $658k–$4.1M; Series A $4.4M–$24M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • DESKi — HeartFocus is an AI-powered heart exam software for ultrasound and can be used with any hand-held probe, cart or ultrasound system. The product is available as an APP or SDK and is appropriate for clinics, health systems and learning institutions
  • Praysbee — Praysbee is a French agri-tech startup that develops innovative, environmentally friendly spraying systems for vineyards. Their main product, the Wulp® boom, reduces chemical drift by over 90%, helping winegrowers spray more precisely and sustainably.
  • Hypr Space (Hybrid Propulsion for Space) — Get ready for the next technology leap in space industry. We develop engines and vehicles that are cheaper, quicker and greener for earth to space and space to space transportation systems. Our patented innovation is based on brand new architecture for hybrid propulsion engines, unlocking previously unreachable capabilities.
Show all investments...

Capital Grand Est
VC Fund · Schiltigheim, Alsace, France · 3 investments in France Medical Device startups

Capital Grand Est is a private equity firm that focuses on supporting businesses. Capital Grand Est was founded in 2012 and was headquartered in Schiltigheim, France.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$13M; Series A $2.6M–$19M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • SEEQLE — Seeqle is an AI-driven recruitment and talent acquisition platform founded in 2018 and headquartered in Nancy and Paris. By seamlessly integrating programmatic advertising with advanced candidate pre-screening, Seeqle empowers HR teams and training organizations to automate the entire hiring lifecycle—from crafting hyper-targeted campaigns (SeeqleTalent Ads) across 2 million+ web, social, video and audio channels, to enriching, scoring and predicting candidate success with its CRM/ATS module (Seeqle Talent CRM). Leveraging a proprietary dataset of 380 000+ socio-professional signals and continuous machine-learning refinements, Seeqle enables clients in 8 countries to attract up to 5× more qualified applicants, cut time-to-hire by over 50%, and maintain real-time budget optimization.Seeqle’s suite includes personality profiling (MBTI-style analysis), hidden-skill detection, career-path forecasting and automated rejection emails, all accessible via a unified dashboard. The company has raised €2.5 million to date, serves Fortune 500 clients and high-growth SMEs alike, and has earned five industry awards for its innovation in HR Tech. With plans to expand into North America and deepen its AI capabilities, Seeqle is redefining how organizations source, evaluate and engage talent at scale.
  • EVerZom — EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration.
  • RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.
Show all investments...

ACG Management
VC Fund · Marseille, Provence-Alpes-Cote d'Azur, France · 3 investments in France Medical Device startups

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: France, Madagascar

Investor stats

  • Total investments: 49
  • Round size: Seed $878k–$2.9M; Series A $1.5M–$7.2M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2013

Portfolio highlights

  • Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
  • Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
  • My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
Show all investments...

LBO France
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

A pioneer in private equity in France, LBO France is now a leading multi-specialist, multi-country investment platform.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: France, United Kingdom, Spain

Investor stats

  • Total investments: 37
  • Round size: Series A $3.3M–$18M; Series B $16M–$191M; Venture - Series Unknown $2.4M–$77M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $181M in 2021

Portfolio highlights

  • Toothfairy — Winner of app of the year, for emergencies, teeth straightening, teeth whitening & prescriptions. Teledentistry and dentist available 24/7. Founded by dentists.
  • Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
  • Siteflow — For many years digital transformation of the manufacturing industry has been underway. However, for regulated industries and operations that combine complex reporting workflows, project manufacturing and mobility for the field, few digital solutions meet the expectations. As a result, on those sites, tools and work methods haven’t changed so muchthe past decades while quality and safety requirements have exploded.That is around those challenges that professionnals from the nuclear industry, special works and software experts have gathered, to create Siteflow, the first cloud-based field service management software designed for complex operations (Nuclear, Oil&Gas…).A solution designed for end-userBeyond technical specificities from those markets, we have leveraged learnings from industries that have already been through digital transformation: every time user acceptance is key to make those challenging projects a success.This is why at Siteflow, our obsession is to design the most simple interfaces, and functionalities that bring value directly for our users, in order to simplify their daily tasks, to ease collaboration with their colleagues and to help them focus on what really matters.A change management program to facilitate digital transformationAs we all know, the choice of a software solution is just part of the puzzle to implement a digital transformation program. Organizations need to be re-designed as day-to-day activities of engineers, project managers and operators are directly concerned. Based upon our experience, we help our customers for a smooth transition to operational excellence.
Show all investments...

Mutuelles Impact
VC Fund · 3 investments in France Medical Device startups

Mutuelles Impact Initiated by the Mutualité Française and financed by 45 mutuals and the Mutualité Française, the Mutuelles Impact fund aims to invest and develop companies with a high social impact in the sectors of prevention, care pathways, and medico-social.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Software
  • Stage:Seed, Venture - Series Unknown
  • Geography: France, Germany, Switzerland

Investor stats

  • Total investments: 15
  • Round size: Seed $2.3M–$15M; Venture - Series Unknown $6.5M–$25M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Lifeaz — Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators.
  • Semeia — Semeia provides software that helps in medical follow-up and consultation.
  • Mindday — Mindday is reinventing mental well-being by combining human support, digital programs and science to provide immediate and personalized support to anyone.
Show all investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 3 investments in France Medical Device startups

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Private Equity
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 57
  • Round size: Series A $5.7M–$22M; Private Equity $22M–$150M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $417M in 2020

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
IXcore
VC Fund · Marly-le-roi, Ile-de-France, France · 3 investments in France Medical Device startups

IXcore, a healthcare investment company, focuses on early-stage investments in the biotechnology and diagnostics fields.

Show more...

Investment focus

  • Industry: Manufacturing, Medical Device, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Israel

Investor stats

  • Total investments: 14
  • Round size: Seed $1.1M–$8.8M; Pre-Seed $1.7M–$8.7M; Series A $3M–$17M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • OWLO — OWLO is a Medical Equipment Manufacturing firm building next generative microscopic real time 3D image for healthcare.
  • IMMA — At Home Ovarian Stimulation Monitoring System For IVF - RE-INVENTING THE FERTILITY EXPERIENCE
  • IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
Show all investments...

Sham Innovation Santé
VC Fund · Lyon, Rhone-Alpes, France · 3 investments in France Medical Device startups

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Series B, Series A
  • Geography: France

Investor stats

  • Total investments: 16
  • Round size: Series A $5.7M–$74M; Series B $9.9M–$80M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Région Sud Investissement
VC Fund · Marseille, Provence-Alpes-Cote d'Azur, France · 3 investments in France Medical Device startups

Région Sud Investissement is an investment Firm.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Spain

Investor stats

  • Total investments: 60
  • Round size: Seed $1.1M–$5.8M; Series A $2.2M–$22M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Agriodor — Agriodor is to provide concrete and effective alternatives to insecticides to help farmers produce more sustainably.
  • K-Motors — K-Motors develops modules that improve the battery cycle of electric vehicles and motors.
  • MYCOPHYTO — Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection.
Show all investments...

Pays de la Loire Participations
VC Fund · Nantes, Pays de la Loire, France · 3 investments in France Medical Device startups

Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Seed, Private Equity
  • Geography: France

Investor stats

  • Total investments: 52
  • Round size: Seed $549k–$3.3M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • CGREEN — CGREEN is developing a biosourced, low-carbon carbon fiber derived from cellulose — a renewable, local, and abundant resource.
  • Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
  • Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
Show all investments...

MD Start
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Medical
  • Stage:Seed, Series B
  • Geography: France

Investor stats

  • Total investments: 4
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • HEPTA Medical — HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.
  • Gradient Denervation Technologies — First purpose-built, minimally invasive, ultrasound-based system designed to treat patients with pulmonary hypertension due to left-sided heart disease.
Show all investments...

Crédit Mutuel Innovation
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 97
  • Round size: Series A $3.3M–$26M; Series B $6.7M–$43M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • STIMIO — Anticipation de pannes, priorisation d'actions de maintenance, optimisation de l'exploitation avec les solutions IoT de Stimio.
  • Invenis — Invenis Helps Data Driven Businesses Taking Better Business Decisions Powered by Big Data and Artificial Intelligence
  • Standing Ovation — Animal-free dairy cheese
Show all investments...

Cap Innov'Est
VC Fund · Illkirch-graffenstaden, Alsace, France · 3 investments in France Medical Device startups

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $713k–$2.7M; Series A $7.5M–$7.7M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $42M in 2014

Portfolio highlights

  • PeptiMimesis — PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors.PeptiMimesis will develop its pipeline against keytargets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
  • Inoviem Scientific — Our groundbreaking label-free technologies enable you to detect and identify the clinical power of, and weaknesses in, your compound from early-stage pre-clinical R&D through to clinical trials
  • Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 3 investments in France Medical Device startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 489
  • Round size: Post-IPO Debt $16M–$658M; Debt Financing $16M–$370M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
  • RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Show all investments...

ODYSSEE VENTURE
VC Fund · Paris, Ile-de-France, France · 3 investments in France Medical Device startups

ODYSSEE VENTURE is a French Venture Capital and Private Equity firm. It was founded by Mathieu Boillet and Sébastien Sassolas in 1999 and is based in Paris, France. The company has raised over 600M€.

Show more...

Investment focus

  • Industry: Software, Information Technology, Analytics
  • Stage:Series A, Private Equity
  • Geography: France, United States

Investor stats

  • Total investments: 84
  • Round size: Series A $1.6M–$11M; Private Equity $2.2M–$6.4M
  • Lead/follow: 75% lead, 25% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Veesion — Veesion: AI-driven smart video surveillance. Detect theft in real time. Protect your business now.
  • Terratis — Terratis is a French company that uses the Sterile Insect Technique (SIT) to reduce the populations of tiger mosquitoes and agricultural pests. Their mission is to diminish harmful insect populations effectively on a large scale using a scientific, innovative, ecological, and efficient approach.
  • BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Show all investments...

MACSF
VC Fund · La Défense, Ile-de-France, France · 3 investments in France Medical Device startups

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Seed
  • Geography: France, Spain, Ecuador

Investor stats

  • Total investments: 26
  • Round size: Seed $1.1M–$24M; Series A $7.7M–$44M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
  • Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
  • RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.
Show all investments...

Medical Device Investor funding in France at a glance

Stats across 447 deals from 503 investors.

503
investors
in France Medical Device startups
447
deals
in France Medical Device startups
$5.5M
median round
in France Medical Device startups
41%
lead investors
lead at least one round
21%
Seed
most common funding stage
95/5
VC / Angel
share of investor count

Access all 503 investors in France Medical Device startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 503 investors investing in France Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists